Atai Life Sciences Stock Investor Sentiment

ATAI Stock  USD 1.91  0.07  3.54%   
Under 56% of ATAI Life's investor base is looking to short. The analysis of the overall investor sentiment regarding ATAI Life Sciences suggests that many traders are alarmed. ATAI Life's investor sentiment overview provides quick insight into current market opportunities from investing in ATAI Life Sciences. The current market sentiment, together with ATAI Life's historical and current headlines, can help investors time the market. In addition, many technical investors use ATAI Life Sciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
ATAI Life stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of ATAI daily returns and investor perception about the current price of ATAI Life Sciences as well as its diversification or hedging effects on your existing portfolios.
  

ATAI Life Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards ATAI Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
2 days ago at investing.com         
atai Life Sciences reports positive Phase 1 results for BPL-003
Investing News at Macroaxis
2 days ago at globenewswire.com         
atai Life Sciences Announces the Publication of Beckley Psytechs Phase 1 Study of BPL-003 in the Jou...
Macroaxis News: globenewswire.com
few days ago at www.macroaxis.com         
Disposition of 147950 shares by Apeiron Investment Group Ltd. of ATAI Life subject to Rule 16b-3
Macroaxis News
over a week ago at news.google.com         
IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences - The Glob...
Google News at Macroaxis
over a week ago at benzinga.com         
ATA Creativity Global Announces Filing of Annual Report on Form 20-F for the Year Ended December 31,...
benzinga news
over two weeks ago at investing.com         
Atai Life Sciences executive sells 114k in company stock
Investing News at Macroaxis
over two weeks ago at zacks.com         
Are You Looking for a Top Momentum Pick Why atai Life Sciences N.V. is a Great Choice
zacks News
over two weeks ago at investing.com         
Atai Life Sciences CFO sells 50,708 in company stock
Investing News at Macroaxis
over two weeks ago at investing.com         
Atai Life Sciences executive sells 66k in company stock
Investing News at Macroaxis
over two weeks ago at seekingalpha.com         
Atai Life Sciences stock upgraded at Maxim
seekingalpha News
over two weeks ago at www.macroaxis.com         
Disposition of 35801 shares by Kirpekar Sahil of ATAI Life at 1.85 subject to Rule 16b-3
Macroaxis News
over two weeks ago at finance.yahoo.com         
Atai Life Sciences Full Year 2023 Earnings EPS Beats Expectations, Revenues Lag
Yahoo News
over two weeks ago at simplywall.st         
Atai Life Sciences Full Year 2023 Earnings EPS Beats Expectations, Revenues Lag
Simply Wall St News at Macroaxis
over two weeks ago at globenewswire.com         
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporat...
Macroaxis News: globenewswire.com
over two weeks ago at investorplace.com         
ATAI Stock Earnings ATAI Life Sciences Beats EPS, Misses Revenue for Q4 2023
sbwire news
Far too much social signal, news, headlines, and media speculation about ATAI Life that are available to investors today. That information is available publicly through ATAI media outlets and privately through word of mouth or via ATAI internal channels. However, regardless of the origin, that massive amount of ATAI data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ATAI Life news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ATAI Life relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ATAI Life's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ATAI Life alpha.

ATAI Life Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
03/04/2024
2
Acquisition by Rao Srinivas of 800000 shares of ATAI Life at 1.84 subject to Rule 16b-3
03/13/2024
3
Disposition of 350000 shares by Florian Brand of ATAI Life subject to Rule 16b-3
03/14/2024
4
Acquisition by Gutierrez-esteinou Rolando of 500000 shares of ATAI Life at 1.18 subject to Rule 16b-3
03/20/2024
5
ATAI LIFE SCIENCES B.V. Trade Ideas SWB9VC TradingView - TradingView
03/22/2024
6
Disposition of 200000 shares by Anne Johnson of ATAI Life subject to Rule 16b-3
03/26/2024
7
atai Life Sciences Announces Positive Initial Results from Beckley Psytechs Phase 2a Open Label Study of BPL-003 in Treatment Resistant Depression
03/27/2024
8
ATAI Stock Earnings ATAI Life Sciences Beats EPS, Misses Revenue for Q4 2023
03/28/2024
9
Disposition of 35801 shares by Kirpekar Sahil of ATAI Life at 1.85 subject to Rule 16b-3
04/02/2024
10
Atai Life Sciences stock upgraded at Maxim
04/03/2024
11
Atai Life Sciences executive sells 66k in company stock
04/04/2024
12
IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences - The Globe and Mail
04/11/2024
13
Disposition of 147950 shares by Apeiron Investment Group Ltd. of ATAI Life subject to Rule 16b-3
04/15/2024
14
atai Life Sciences Announces the Publication of Beckley Psytechs Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
04/17/2024
When determining whether ATAI Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ATAI Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atai Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atai Life Sciences Stock:
Check out ATAI Life Hype Analysis, ATAI Life Correlation and ATAI Life Performance.
Note that the ATAI Life Sciences information on this page should be used as a complementary analysis to other ATAI Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for ATAI Stock analysis

When running ATAI Life's price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is ATAI Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.97)
Earnings Share
(0.25)
Revenue Per Share
0.002
Quarterly Revenue Growth
(0.53)
Return On Assets
(0.26)
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.